trial · primary record
Intismeran
Non-small Cell Lung Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 876 |
| Primary completion | 2038-05-11 |
| Primary endpoint | Disease-Free Survival (DFS) as Assessed by Blinded Independent Central Review (BICR) in Participants With Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Arm A and Arm C |
| Registry ID | NCT07513376 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:36.686Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07513376
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.